Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Women with PCOS have different hormone levels than those without it.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Skin cancer in sun-exposed areas is more likely to come back.

Melanoma characteristics vary by age, which could help doctors with diagnosis and prevention.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Macular alopecia is a distinct, non-scarring hair loss pattern that mostly affects young Hispanic/Latinx females and often resolves on its own.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Alopecia totalis/universalis is linked to more autoimmune diseases than patchy alopecia areata.

Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.

Combining concentrated growth factor with intense pulsed light is more effective and safer for sensitive skin than using intense pulsed light alone.

Androgenetic alopecia is not linked to higher heart disease risk.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

Hair mesotherapy with peptides and nutrients improves hair growth in androgenetic alopecia.

The treatment effectively improved hair growth and was well tolerated in most men.

Digital care for hair loss significantly improves men's quality of life.

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Statins do not help improve alopecia areata.

Statins do not help improve alopecia areata.

Severe COVID-19 increases the risk of hair loss.